SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-006773
Filing Date
2014-01-09
Accepted
2014-01-09 17:15:59
Documents
3
Period of Report
2014-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d656124d8k.htm 8-K 19788
2 EX-99.1 d656124dex991.htm EX-99.1 7101
3 EX-99.2 d656124dex992.htm EX-99.2 8434
  Complete submission text file 0001193125-14-006773.txt   36724
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 14519438
SIC: 8731 Services-Commercial Physical & Biological Research